Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors

Cerebrospinal fluid is a fluid that circulates within the subarachnoid space between the brain surface and the meningeal layers, providing mechanical protection and metabolic support to the central nervous system. During neurosurgical procedures for intracranial tumors, opening of the meningeal layers, including the dura mater, is routinely required to access deeper cerebral structures. At the conclusion of surgery, meticulous dural closure is performed to restore a watertight barrier. However, in certain cases, dural reconstruction may be insufficient, resulting in postoperative cerebrospinal fluid leakage.

Cerebrospinal fluid leakage may manifest as accumulation of fluid beneath the scalp tissues or as external drainage through the surgical wound margins. The presence of cerebrospinal fluid leakage compromises normal wound healing and increases the risk of postoperative complications, including superficial and deep surgical site infections. These complications may delay wound healing, prolong hospitalization, and affect the timing of postoperative adjuvant therapies such as radiotherapy or chemotherapy in patients with intracranial tumors. Although cerebrospinal fluid leakage is more commonly associated with infratentorial procedures, it remains a significant and challenging complication following supratentorial craniotomy. Despite its clinical relevance, cerebrospinal fluid leakage after supratentorial tumor surgery is relatively under investigated, and data regarding its incidence, risk factors, and optimal management strategies remain limited. This prospective observational study aims to evaluate the incidence of cerebrospinal fluid leakage following supratentorial craniotomy for intracranial tumors, identify patient and surgery related risk factors, and assess the effectiveness of various management and treatment modalities. All patients undergoing supratentorial craniotomy for intracranial tumor resection will be prospectively observed, and those who develop postoperative cerebrospinal fluid leakage will be identified and analyzed. Data collection will include tumor related anatomical characteristics, dural closure techniques, materials used for dural reconstruction, and therapeutic interventions employed for the management of cerebrospinal fluid leakage. Patients will be followed for a period of six weeks postoperatively, corresponding to the typical timeframe for initiation of adjuvant oncological treatment. The findings of this study aim to improve understanding of cerebrospinal fluid leakage in supratentorial craniotomies and may contribute to the development of strategies to reduce its incidence and associated complications in the future.

• Surgical site infections incidence. [Срок оценки: From the enrollment till the end of observation period (6 weeks postoperatively).]
• Unplanned outpatient clinic or emergency department visits due to cerebrospinal fluid leak. [Срок оценки: From the enrollment till the end of observation period (6 weeks postoperatively) or resolution of cerebrospinal fluid leak.]
• Hospitalization due to cerebrospinal fluid leak. [Срок оценки: From the enrollment till the end of observation period (6 weeks postoperatively) or resolution of cerebrospinal fluid leak.]
• Treatment modalities of cerebrospinal fluid leak. [Срок оценки: From the enrollment till the end of observation period (6 weeks postoperatively) or resolution of cerebrospinal fluid leak.]
• Antibiotic therapy. [Срок оценки: From the enrollment till the end of observation period (6 weeks postoperatively) or resolution of cerebrospinal fluid leak.]
• Dura restoration techniques. [Срок оценки: From the enrollment till the end of observation period (6 weeks postoperatively).]
• Scalp incision type. [Срок оценки: From the enrollment till the end of observation period (6 weeks postoperatively) or resolution of cerebrospinal fluid leak.]
• Skin closure techniques. [Срок оценки: From the enrollment till the end of observation period (6 weeks postoperatively).]
• Cerebrospinal fluid leak occurrence timing. [Срок оценки: From the enrollment till the end of observation period (6 weeks postoperatively).]